CoChat

Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models

Open access
Green, Charlotte J., Parry, Siôn A., Gunn, Pippa J., Ceresa, Carlo D.L., Rosqvist, Fredrik, Piché, Marie-Eve, Hodson, Leanne · 2020 · Hormone Molecular Biology and Clinical Investigation
Cited by 37

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing. Determining the pathogenesis and pathophysiology of human NAFLD will allow for evidence-based prevention strategies, and more targeted mechanistic investigations. Various in vivo, ex situ and in vitro models may be utilised to study NAFLD; but all come with their own specific caveats. Here, we review the human-based models and discuss their advantages and limitations in regards to studying the development and progression of NAFLD. Overall, in vivo whole-body human studies are advantageous in that they allow for investigation within the physiological setting, however, limited accessibility to the liver makes direct investigations challenging. Non-invasive imaging techniques are able to somewhat overcome this challenge, whilst the use of stable-isotope tracers enables mechanistic insight to be obtained. Recent technological advances (i.e. normothermic machine perfusion) have opened new opportunities to investigate whole-organ metabolism, thus ex situ livers can be investigated directly. Therefore, investigations that cannot be performed in vivo in humans have the potential to be undertaken. In vitro models offer the ability to perform investigations at a cellular level, aiding in elucidating the molecular mechanisms of NAFLD. However, a number of current models do not closely resemble the human condition and work is ongoing to optimise culturing parameters in order to recapitulate this. In summary, no single model currently provides insight into the development, pathophysiology and progression across the NAFLD spectrum, each experimental model has limitations, which need to be taken into consideration to ensure appropriate conclusions and extrapolation of findings are made.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1515/hmbci-2018-0038

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 37

Metadata

Authors
Green, C. J., Parry, S. A., Gunn, P. J., Ceresa, C. D. L., Rosqvist, F., Piché, M.-E., & Hodson, L.
Venue
Hormone Molecular Biology and Clinical Investigation
Published
2018-08-11
Volume
41
Issue
1
ISSN
  • 1868-1883 (ISSN-L)
  • 1868-1891
OpenAlex
W2886584202
Cited by
37
References
28
FWCI
1.53
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models. https://app.cochat.ai/papers/10.1515/hmbci-2018-0038
The paper
Green, C. J., Parry, S. A., Gunn, P. J., Ceresa, C. D. L., Rosqvist, F., Piché, M.-E., & Hodson, L. (2020). Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models. Hormone Molecular Biology and Clinical Investigation. https://doi.org/10.1515/hmbci-2018-0038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.